Local Stocks
Energy Stocks
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Fate Therapeutics (NQ: FATE)
14.71 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 7:56 AM EDT, Oct 23, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 17
Open 14.71
Bid (Size) 14.17 (1)
Ask (Size) 14.99 (1)
Prev. Close 14.71
Today's Range 14.71 - 14.71
52wk Range 11.00 - 22.82
Shares Outstanding 52,858,446
Dividend Yield N/A
Performance
YTD
+8.72%
+8.72%
1 Month
-15.09%
-15.09%
3 Month
-34.62%
-34.62%
6 Month
-13.16%
-13.16%
1 Year
+23.30%
+23.30%
Top News
More News
Fate Therapeutics Announces the Opening of its cGMP Manufacturing Facility Dedicated to iPSC-derived Cell Therapies
State-of-the-Art Facility Designed to use Clonal Master iPSC Lines as Renewable Cell Source for Manufacture of Off-the-Shelf Product Pipeline Read More
from GlobeNewswire News Releases
Fate Therapeutics Announces Completion of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
from GlobeNewswire News Releases
More News
Read More
First Week of FATE December 20th Options Trading
category Stocks
from Market News Video
Fate Therapeutics Announces Pricing of Public Offering of Common Stock
from GlobeNewswire News Releases
Notable Thursday Option Activity: FATE, CXW, LRCX
category Stocks
from Market News Video
Fate Therapeutics Announces Proposed Public Offering of Common Stock
from GlobeNewswire News Releases
Stifel Bullish On Iovance And Fate Therapeutics, Neutral On Bluebird Bio
category Price Target , General , BLUE , and 10 more.
from Benzinga
FATE Crosses Below Key Moving Average Level
category Stocks
from Market News Video
Investors Bag FATE Even Cheaper Than Its Secondary Stock Offering
category Stocks
from Market News Video
Fate Therapeutics Hits 80-Plus Relative Strength Rating Benchmark
from Investor's Business Daily
FYX's Underlying Holdings Imply 12% Gain Potential
category ETFs
from ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.